Justia Blawg Search - Law Blogs, Lawyer Blogs, Legal Blogs Directory & Search Engine

DOJ Claims Teva Pharmaceuticals Paid Illegal Kickbacks, Artificially Inflated Price Of Drugs

11 Sep 2020, 7:06 am by Peter Briccetti

The U.S. government filed a False Claims Act case against Teva Pharmaceuticals USA Inc. and Teva Neuroscience Inc. [read post]

Whistleblower Protection Blog - http://www.whistleblowersblog.org/

Department of Justice sues Teva Pharmaceuticals over copayment kickbacks

30 Aug 2020, 10:19 am by Ben Vernia

According to DOJ’s press release: The United States has filed a False Claims Act complaint against Teva Pharmaceuticals USA Inc. and Teva Neuroscience Inc. [read post]

False Claims Counsel - http://www.falseclaimscounsel.com/wordpress

IBSA Institut Biochimique, S.A. v. Teva Pharmaceuticals USA, Inc. (Fed. Cir. 2020)

13 Aug 2020, 9:59 pm by Patent Docs

Teva Pharmaceuticals USA, Inc., affirmed a District Court's finding that the asserted claims to a pharmaceutical formulation were indefinite. [read post]

Patent Docs - http://www.patentdocs.org/

CAFC reviews "disclosed, not claimed, dedicated" in Eagle Pharmaceuticals; D. Delaware affirmed

8 May 2020, 6:57 pm by Lawrence B. Ebert

USA,Inc., 429 F.3d 1364, 1378 (Fed. [read post]

IPBiz - http://ipbiz.blogspot.com/

U.S. Court of Appeals for the Federal Circuit, Personalized Media Communications, LLC v. Apple, Inc., Docket No. 18-1936

1 Apr 2020, 3:36 pm

USA, Inc., 731 F.3d 1271, 1276 (Fed. [read post]

Frederic Borel - http://fredericborel.blogspot.ch/

Utilization of Natural Phenomenon Found Patent Eligible

31 Mar 2020, 9:58 am by Antoinette F. Konski

USA, Inc., 919 F.3d 1347 (Fed. [read post]

Personalized Medicine Bulletin - https://www.foley.com/en/insights/blogs/personalized-medicine-bulletin

ND Cal reversed by CAFC in Illumina case

24 Mar 2020, 1:24 am by Lawrence B. Ebert

USA, Inc., 919 F.3d 1347 (Fed.Cir. 2019); Natural Alternatives Int'l, Inc. v. [read post]

IPBiz - http://ipbiz.blogspot.com/

FDA Recall Watch

17 Mar 2020, 1:32 pm by Noble McIntyre

One Lot of Topotecan Injection 4 mg/4 mL (1 mg/mL) has been recalled by Teva Pharmaceuticals due to the presence of particulate matter. [read post]

Oklahoma Law Blog - http://www.oklahoma-law.com/blog/

Necessity Is The Mother Of Single Reference Anticipation By Inherency

25 Feb 2020, 2:10 am by Courtenay C. Brinckerhoff

Teva Pharmaceuticals USA, Inc., is a non-precedential decision that was issued on the briefs (without oral argument), but is worth reviewing for its discussion of anticipation and inherency in the context of method of treatment claims. [read post]

PharmaPatents - https://www.foley.com/en/insights/blogs/pharmapatents

Guest Post by Prof. Holbrook: Whose Law Controls On Sale Prior Art in Foreign Countries?

4 Feb 2020, 5:00 am by Jason Rantanen

Teva Pharmaceuticals USA, Inc., the Supreme Court, in its first case addressing the AIA’s § 102, rejected this argument. [read post]

Patently-O - http://patentlyo.com/patent

Supporting Amendment to 35 U.S.C. Section 102(a) Clarifying Public Disclosure

27 Jan 2020, 7:42 am by Dennis Crouch

USA, Inc., 139 S. [read post]

Patently-O - http://patentlyo.com/patent

Split decision in Virnetx v/ Apple

22 Nov 2019, 2:56 pm by Lawrence B. Ebert

USA, Inc. v. [read post]